Introduction
============

*Campylobacter jejuni* and related species are commensals in many birds and domestic mammals, and have been recognized as being the most important cause of bacterial food poisoning worldwide. Infections with *C. jejuni* are the major cause of human bacterial gastroenteritis, and may be responsible for as many as 400--500 million cases worldwide each year (Friedman et al., [@B27]). Disease outcomes vary from mild, non-inflammatory, self-limiting diarrhea to severe, inflammatory, bloody diarrhea lasting for several weeks, but *C. jejuni* is also associated with the development of the reactive arthritis and peripheral neuropathies, the Miller--Fisher and Guillain--Barrè syndromes in a minority of individuals (Young et al., [@B99]). The publication of numerous complete genome sequences of different *C. jejuni* strains has revealed an organism that displays a large degree of strain to strain variation. This natural heterogeneity has made studying the pathogenicity of this pathogen particularly challenging. However, significant progress has been made in recent years which has contributed to our understanding of the role of several key factors including the cytolethal distending toxin (Lara-Tejero and Galán, [@B60]; Ge et al., [@B28]) as well as glycosylation and molecular mimicry processes (Guerry and Szymanski, [@B32]; Nothaft and Szymanski, [@B72]). One of the key differences between infection of humans and chickens by *C. jejuni* is the apparently increased number of bacteria invading epithelial cells in the human host (Young et al., [@B99]). This suggests that both bacterial adherence to and entrance into epithelial cells may be critical steps that are essential for disease development. Thus, the identification of factors involved in these processes is the key for developing therapeutics to treat infections as well as enhancing our understanding of the pathogenesis.

There are two general strategies which the multitude of enteric bacterial pathogens use to enter host target cells. According to specific characteristics of the invasion process, we can distinguish between the classical "zipper"- and "trigger"-mechanisms, respectively (Cossart and Sansonetti, [@B18]). The "zipper"-mechanism is initiated by one or more bacterial surface proteins (commonly comprising adhesins and invasins) which bind to one or more specific host cell receptors followed by internalization, as reported for *Yersinia* or *Listeria* species (Figure [1](#F1){ref-type="fig"}A). On the other hand, the "trigger"-mechanism involves type-III and type-IV secretion systems (T3SSs and T4SSs) injecting bacterial proteins which often mimic or hijack specific host cell factors to trigger the bacterial uptake process, as described for *Salmonella* and *Shigella* (Figure [1](#F1){ref-type="fig"}B). Genome analyses revealed a notable absence of these classical pathogenicity factors in *C. jejuni*, making predictions very difficult. Since a suitable animal model system mimicking human infection is not available, a wide variety of *in vitro* cell culture models have been applied to identify the *C. jejuni* factors that play a role in adherence and invasion (Table [1](#T1){ref-type="table"}). Unfortunately, the use of different *C. jejuni* strains and various cell models of infection led to substantial confusion and controversies in the literature. This review aims to summarize recent developments and to outline the experimental evidence for factors with proposed roles in adhesion and invasion. We discuss the pro's and con's of these findings in order to see whether *C. jejuni* may utilize a "zipper" or "trigger" mechanism of host cell invasion.

![**Primary mechanisms of bacterial invasion into non-phagocytic host cells**. Schematic representation of the two different routes of entry by intracellular bacterial pathogens. The pathogens induce their own uptake into target cells by subversion of host cell signaling pathways using the "zipper" and "trigger" invasion mechanism, respectively. **(A)** Bacterial gastrointestinal pathogens commonly colonize the gastric epithelium \[step 1\]. The "zipper" mechanism of invasion involves the high-affinity binding of bacterial surface adhesins to their cognate receptors on mammalian cells \[step 2\], which is required to initiate cytoskeleton-mediated zippering of the host cell plasma membrane around the bacterium \[step 3\]. Subsequently the bacterium is internalized into a vacuole. Some bacteria have developed strategies to survive within, or to escape from this compartment \[step 4\]. **(B)** The "trigger" mechanism is used by *Shigella* or *Salmonella* spp. which also colonize the intestinal epithelium \[step 1\]. These pathogens use sophisticated type-III or type-IV secretion system to inject various effector proteins into the host cell cytoplasm \[step 2\]. These factors manipulate a variety of signaling events including the activation of small Rho GTPases and cytoskeletal reorganization to induce membrane ruffling and subsequently bacterial uptake \[step 3\]. As a consequence of this signaling, the bacteria are internalized into a vacuole \[step 4\], followed by the induction of different signaling pathways for intracellular survival and trafficking. This figure was adapted from Tegtmeyer et al. ([@B90]) with kind permission from Springer Publishing. **(C)** Scanning electron microscopy of *C. jejuni* 81-176 invasion. Invading bacteria (yellow arrows) were regularly associated with membrane ruffles (red arrows) and filopodia-like structures (blue arrows). This figure was adapted from Boehm et al. ([@B12]). **(D)** Electron micrographs of *C. jejuni*--containing vacuoles (CCVs) that do not co-localize with BSA-gold (left) and CCVs that co-localize with BSA-Gold and resemble lysosomes (right, arrows) are shown. The two pictures were kindly provided by Dr. Galan (Watson and Galán, [@B94]). **(E)** The electron micrograph of translocating *C. jejuni* across polarized Caco-2 cells by the paracellular pathway was kindly provided by Dr. Konkel (Konkel et al., [@B51]).](fcimb-02-00025-g001){#F1}

###### 

**Bacterial factors and proposed roles in *C. jejuni* infection**.

  Bacterial factor                                        Proposed function                               Applied experimental methods                                                                                   Strains used                   Cell system used          Reference
  ------------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------------------------------------------------------- ------------------------------ ------------------------- -----------------------------------------------------------------------------------------------------
  AspA, AspB                                              Aspartate ammonia lyase and amino transferase   Infection *in vitro*, GPA, ISA                                                                                 81-176                         T84                       Novik et al. ([@B74])
  CadF                                                    Adhesin to fibronectin                          Infection *in vitro* and in chickens, GPA, FBA, CBA, ELISA                                                     F38011, 11168, 81-176          INT-407, T84, LMH         Konkel et al. ([@B49]), Ziprin et al. ([@B100]), Monteville et al. ([@B68]), Scott et al. ([@B86])
  CapA                                                    Adhesin/Invasin                                 Infection *in vitro* and chickens, GPA                                                                         11168, F38011                  Caco-2, LMH               Ashgar et al. ([@B3]), Flanagan et al. ([@B26])
  CDT                                                     Cytolethal distending toxin                     Treatment of cells *in vitro*, MI, FACS, IFM, DNAse assays                                                     81-176                         COS-1, REF52, Henle-407   Lara-Tejero and Galán ([@B60])
  CiaB, CiaC                                              Invasin                                         Infection *in vitro*, GPA, MLA, T3SS assays                                                                    F38011, 11168                  INT-407                   Konkel et al. ([@B54]), Christensen et al. ([@B17])
  CiaI                                                    Intracellular survival                          Infection *in vitro*, GPA, MLA, IFM                                                                            F38011                         INT-407, HeLa             Buelow et al. ([@B14])
  CJ0977[^a^](#tfn1){ref-type="table-fn"}                 Invasion                                        Infection *in vitro* and ferrets, EM, MA, GPA                                                                  81-176                         INT-407                   Goon et al. ([@B29])
  CstII                                                   LOS sialylation                                 Infection *in vitro*, GPA                                                                                      GB2, GB11, GB19                Caco-2, T84               Louwen et al. ([@B63])
  FlaC                                                    Invasin                                         Infection *in vitro*, MA, EM, cell fractionation, GPA, IFM                                                     TGH9011                        HEp-2                     Song et al. ([@B87])
  FlpA                                                    Adhesin to fibronectin                          Infection *in vitro* and in chickens, FBA, ABB, GPA, IFM, ELISA                                                F38011                         INT-407, Hela, LMH        Flanagan et al. ([@B26]), Konkel et al. ([@B55]), Eucker and Konkel ([@B24])
  FspA                                                    Apoptosis                                       BRP, AA                                                                                                        81-176, CG8486                 INT-407                   Poly et al. ([@B79])
  GGT                                                     Gamma-glutamyl transpeptidase                   Infection *in vitro*, mice and chickens, cell fractionation, MA, GPA, HPS, AA                                  RM1221, 81-176, 81116, 11168   INT-407, CCD841 CoN       Hofreuter et al. ([@B35], [@B34]), Barnes et al. ([@B9])
  HtrA                                                    Periplasmic protease and chaperone              Infection *in vitro*, GPA                                                                                      11168                          INT-407                   Baek et al. ([@B8])
  JlpA[^b^](#tfn2){ref-type="table-fn"}                   Adhesin to HSP90-α, proinflammatory responses   Infection *in vitro*, GPA, BRP, ABB, ligand overlays, geldanamycin inhibitor, p38/NFκB activation using AABs   TGH9011                        HEp-2                     Jin et al. ([@B41]), Jin et al. ([@B42])
  KpsE, KpsM, KpsT                                        Capsule proteins, invasion                      Infection *in vitro*, infection of chicken and ferrets, GPA                                                    81-176, 81116                  INT-407                   Bacon et al. ([@B7]), Bachtiar et al. ([@B4])
  Peb1, Peb3, and Peb4[^c^](#tfn3){ref-type="table-fn"}   Transport proteins and chaperones               Infection *in vitro* and in mice, BRP, GPA                                                                     81-176, 11168                  Hela, INT-407             Leon-Kempis Mdel et al. ([@B61]), Min et al. ([@B66]), Asakura et al. ([@B2]), Kale et al. ([@B44])
  PflA                                                    Motility                                        Infection *in vitro*, GPA                                                                                      81-176                         INT-407                   Yao et al. ([@B97])
  PorA (MOMP)                                             Major outer membrane protein                    Infection *in vitro*, BRP                                                                                      K22, 1767                      INT-407                   Schröder and Moser ([@B84]), Moser et al. ([@B69])
  pVIR                                                    Invasion                                        Infection *in vitro* and in ferrets, GPA                                                                       81-176, VC83                   INT-407                   Bacon et al. ([@B5])
  SodB                                                    Superoxide dismutase                            Infection *in vitro* and in mice, GPA, ISA                                                                     81-176                         T84                       Novik et al. ([@B74])
  VirK                                                    Intracellular survival                          Infection *in vitro* and in mice, GPA, IFM                                                                     81-176                         T84, COS-7                Novik et al. ([@B73])

*AA, apoptosis assay; AB, antibody; AAB, activation-specific antibodies; ABB, antibody blocking; BRP, binding assays using recombinant or purified protein; CBA, competitive binding assay; EM, electron microscopy; FACS, fluorescence-activated cell sorting; FBA, fibronectin binding assay; GPA, gentamicin protection assay; HPS, hydrogen peroxide susceptibility test; IFM, immunofluorescence microscopy; ISA, intracellular survival assay; MI, microinjection of proteins; MA, motility assay on agar; MLA, ^35S^-methionine labeling assay; pVIR, mobilizable plasmid in some strains; T3SS assays, translocation assay using the *Yersinia* flagellar type-III secretion apparatus*.

*^a^Another report indicated that the Cj0097 mutant has a deficiency in motility in liquid broth (Novik et al., [@B74])*.

*^b^Identified as an adhesin in strain TGH9011, but no effect observed with *jlpA* mutants in either 11168 or 81-176 strains (van Alphen et al., [@B92]; Novik et al., [@B74])*.

*^c^These structural studies along with other assays suggest primary roles in protein transport. Originally, the Peb's were identified as putative adhesins (Pei et al., [@B78])*.

Bacterial Motility and Role of the Flagella
===========================================

*Campylobacter jejuni* is a highly motile organism with bipolar flagella which has been reported to be essential for colonization both in humans and animal models (Guerry, [@B31]). The organisms regulate motility through a complex chemotaxis system that allows to swim toward attractants and away from repellants (Lertsethtakarn et al., [@B62]). Early studies revealed that *C. jejuni* motility is required for invasion of epithelial cells *in vitro* as well as showing that increases in mucosal viscosity led to enhanced motility, adherence, and invasion (Szymanski et al., [@B89]). This apparent direct association between motility and invasion combined with the absence of an identifiable classical T3SS or T4SS led some groups to speculate that the flagellum could be also be used as a secretory device for invasion-associated effector molecules. In fact, the flagellum represents a T3SS by definition (Desvaux et al., [@B23]), and a series of papers have been published reporting the extracellular release of *C. jejuni* proteins in the presence of fetal calf serum (FCS) or upon host cell contact, which was abolished when crucial flagellar apparatus genes were inactivated. Additional support came from secretion experiments of *Yersinia* or *C. jejuni* virulence factors through their respective flagellar T3SS model system, suggesting that type-III protein secretion by the flagellum may be a general mechanism for the transport of proteins that influence bacterial--host interactions (Young et al., [@B98]; Christensen et al., [@B17]; Neal-McKinney et al., [@B71]).

The first identified secreted factor was the *Campylobacter* invasion antigen B (CiaB), a 73-kDa protein with weak homology to T3SS effectors of other pathogens (Konkel et al., [@B54]). This paper showed that although *ciaB* mutants had no reduction in adherence to non-polarized INT-407 cells, a significant reduction of intracellular bacteria was observed. CiaB expression was also shown to be essential for the secretion of a whole family of other secreted Cia proteins that were induced in the presence of FCS (Rivera-Amill and Konkel, [@B82]). The CiaB protein was reported to be translocated into the cytoplasm of host cells, suggesting that it is a true effector molecule facilitating invasion (Konkel et al., [@B54]). A later study using a variety of mutants in flagellar subunits reported that the CiaB protein appeared to require at least one of the flagellar subunits for its secretion (Konkel et al., [@B53]). CiaB synthesis is reported to be induced by bile salts (Malik-Kale et al., [@B65]) and both synthesis and secretion can be induced by host cell components suggesting that the protein is under strict environmental regulation (Rivera-Amill et al., [@B81]). However, a very recent study has reported no significant reduction in invasion by a *ciaB* mutant in the model strain 81-176 suggesting that further work is required to confirm the role played by this protein during infection (Novik et al., [@B74]). Since the discovery of CiaB we have seen the emergence of other potential Cia proteins which have been speculated to be important virulence factors. CiaC is such an example and reported to be essential for maximal invasion of INT-407 cells (Christensen et al., [@B17]; Eucker and Konkel, [@B24]). CiaI has also been recently identified as a protein secreted through the flagellar transport system, and appears to play a role in intracellular survival (Buelow et al., [@B14]). Another protein which has been postulated by one group to be secreted through the flagellum is FlaC. This protein has strong homology with the flagellin subunit proteins FlaA and FlaB, and has been shown to play a role in invasion using the HEp-2 *in vitro* cell model (Song et al., [@B87]). The FspA protein which has been shown to induce apoptosis in INT-407 cells has also been reported to be secreted through the flagellum (Poly et al., [@B79]).

CadF and FlpA Fibronectin Binding Proteins
==========================================

Perhaps the most well characterized *C. jejuni* factor interacting with host cells is the CadF protein. CadF was first identified as a 37-kDa protein that bound the extracellular matrix (ECM) protein fibronectin, in either immobilized or soluble form (Konkel et al., [@B49]). The sequence of the *cadF* gene product revealed a protein with homology to an adhesin from *Pseudomonas fluorescens*. In the same year another group confirmed the observation that recombinant CadF bound to fibronectin as well as reporting that the protein could bind to membrane fractions of INT-407 cells *in vitro* (Moser et al., [@B69]). A later study revealed the importance of CadF for colonization, as *cadF* mutants were unable to infect chickens (Ziprin et al., [@B100]). Using the polarized cell line T84 it was reported that *C. jejuni* crossed the epithelial layer between neighboring cells (paracellular route) and invasion might occur through the basolateral but not apical surface (Monteville and Konkel, [@B67]). This study also revealed that CadF expression was required for maximal T84 cell binding. A later study identified the fibronectin binding domain in CadF as four surface-exposed amino acids at position 134--137 (Konkel et al., [@B47]). Mutations in these residues significantly reduced binding to fibronectin and INT-407 cells while peptides containing this putative fibronectin binding site exhibited blocking capacity for binding. Interestingly, Krause-Gruszczynska et al. ([@B58]) have reported that a 39-bp insertion in the *cadF* gene of *C. coli* strains leads to a larger protein and that these strains bind and invade INT-407 cells less efficiently than *C. jejuni*. In *C. jejuni*, CadF expression has been reported to be downregulated in response to human mucin Muc2, suggesting that levels of expression of the protein may vary during the infection cycle (Tu et al., [@B91]). Interestingly, most strains of *C. jejuni* exhibit two bands in Western blots using anti-CadF antibodies, suggesting that distinct forms of the protein may exist. A recent study using mass spectroscopy proposed that CadF may undergo post-translational processing steps, which result in certain cases in the removal of the immunogenic epitope but retention of the fibronectin binding site (Scott et al., [@B86]). The exact role that these different CadF forms play during infection is not yet fully understood.

Recently, a second potential fibronectin binding protein has been identified in *C. jejuni* called FlpA. FlpA was first described as being a protein which played a role in adherence to chicken epithelial cells as well as playing a significant role in colonization of chickens (Flanagan et al., [@B26]). The protein was later described as being capable of binding fibronectin and that *flpA* mutants showed a significant decrease in binding to INT-407 cells as compared to the wild-type strain (Konkel et al., [@B55]). However, neither CadF nor FlpA or any Cia protein were found in a global screen for invasion-related genes in strain 81-176 (Novik et al., [@B74]). A recent study has proposed that CadF and FlpA may act together to target fibronectin for bacterial binding and subsequent invasion by *C. jejuni* (Eucker and Konkel, [@B24]). This indicates that certain additive effects of genes involved in cell adhesion and invasion may play a role. However, inhibitor studies using chloramphenicol showed that bacterial protein synthesis is required for maximal *C. jejuni* invasion (Konkel and Cieplak, [@B48]; Oelschlaeger et al., [@B75]). Chloramphenicol retards the expression of Cia proteins but not CadF or FlpA (Christensen et al., [@B17]; Eucker and Konkel, [@B24]), suggesting that constitutive expression of these adhesins alone is not sufficient for the bacterial uptake process.

Role of JlpA
============

JlpA is a 42-kDa lipoprotein which can be *N*-linked glycosylated at two residues (Scott et al., [@B85]). This surface-exposed lipoprotein has also been implicated as an important adhesin for *C. jejuni*. An initial study in 2001 revealed that *jlpA* mutants exhibit a decreased ability to bind to HEp-2 cells (Jin et al., [@B41]). It was also reported in this study that binding of the wild-type strain could be inhibited by either pre-incubation with recombinant JlpA protein or antibodies raised against JlpA. A later study revealed that recombinant JlpA bound to HEp-2 cells and that the corresponding receptor appeared to be a 90-kDa protein, which was identified as a heat shock protein, HSP90-α (Jin et al., [@B42]). Furthermore, the *jlpA* gene has been shown to be upregulated in response to human mucin along with other *C. jejuni* genes suggesting the protein may play a key role in pathogenicity (Tu et al., [@B91]). However, two other studies have been unable to show a role for JlpA in adherence of *C. jejuni*. One study, using T84 cells, revealed a minimal reduction in invasion with a *jlpA* mutant when compared to the wild-type strain (Novik et al., [@B74]), while the other study which used a chicken epithelial cell line revealed no reduction in invasion of a *jlpA* mutant (Flanagan et al., [@B26]). This study also reported no defect in colonization of broiler chickens by a *jlpA* mutant. Whether these conflicting results are due to strain variation or differences in experimental approaches is not yet clear (Table [1](#T1){ref-type="table"}).

Role of Peb Proteins
====================

One group of *C. jejuni* surface molecules that were originally implicated as being involved in adhesion to epithelial cells are the Peb proteins. These proteins were first described as "CBF proteins," which were observed to range from between 26 to 30-kDa and were shown to be present in bacterial outer membrane fractions which bound to Hela cells (Fauchere et al., [@B25]). These proteins were originally described as being major immunogenic antigens of *C. jejuni* (Pei et al., [@B78]). Peb1 (originally called CBF1) was first described as playing a key role in the adherence to epithelial cells (Fauchere et al., [@B25]). Later studies revealed that Peb1 was surface-exposed and showed that purified Peb1 bound to HeLa cell membranes *in vitro*, and that co-incubation with anti-Peb1 antibodies significantly reduced adherence of *C. jejuni* to intact HeLa cells (Kervella et al., [@B46]). This role in adherence was confirmed when a *peb1* mutant was shown to display a clear reduction in adherence to HeLa cells, invasion of INT-407 cells as well as a significant reduction in its ability to colonize the mouse intestine as compared to the wild-type strain (Pei et al., [@B76]). However, later studies reported that a *peb1* mutant exhibited a minimal reduction in invasion of T84 cells or adherence to chicken epithelial cells, suggesting that the importance of Peb1 in adherence or invasion may vary depending on the assay and cell system used (Flanagan et al., [@B26]; Novik et al., [@B74]).

When the gene encoding Peb1 was originally identified and sequenced, it revealed some homology to proteins involved in amino acid transport systems in other bacteria (Pei and Blaser, [@B77]). A more recent study has confirmed that Peb1 binds aspartate and glutamic acid, and suggested that the protein was predominantly found in the periplasm and not in the inner or outer membranes (Leon-Kempis Mdel et al., [@B61]). These studies may implicate that the primary role of the Peb1 protein may be the utilization of certain amino acids. The recently published crystal structure of Peb1 has identified key domains which may indeed play a role in binding amino acids and may provide a basis for furthering our understanding of how this protein carries out this function and how this affects the ability of the organism to adhere to or invade epithelial cells (Muller et al., [@B70]).

A similar dual role has also been suggested for other reported Peb proteins (Table [1](#T1){ref-type="table"}). Like Peb1, Peb4 had been implicated as a potential adhesin of *C. jejuni* (Kervella et al., [@B46]; Asakura et al., [@B2]). When the nucleotide sequence of Peb4 was first deduced it revealed a gene with homology to factors involved in protein export (Burucoa et al., [@B15]). This role in protein export has since been confirmed by a study showing profound effects on the outer membrane profile in a *peb4* mutant including a reduction in CadF protein levels (Rathbun and Thompson, [@B80]). The recently published crystal structure of Peb4 has confirmed that the protein appears to be a chaperone and may thus play a key role in exporting proteins to the outer membrane and that this may explain its role in adherence (Kale et al., [@B44]). A later study revealed that Peb3 may be a transport protein involved in the utilization of 3-phosphoglycerate (Min et al., [@B66]). These reports highlight the difficulty in identifying the specific mechanism of action of these proposed "adhesins" and further studies are required to discover what exact role the Peb proteins play in *C. jejuni* adherence or invasion.

Other Proposed Factors Involved in Adhesion
===========================================

Several other genes have also been reported as playing a role in either adherence or invasion by *C. jejuni*. The CapA (*Campylobacter* protein A) protein was initially identified as an autotransporter protein and a *capA* mutant displayed reduced adherence to and invasion of Caco-2 cells as well as an inability to colonize chickens (Ashgar et al., [@B3]). A later study confirmed the role of this protein as a putative adhesin or invasin using chicken epithelial cells but revealed no colonization defect in chickens (Flanagan et al., [@B26]). About 40% of human isolates and 39% of chicken isolates in this study lack the *capA* gene, which can explain the reduced bacterial binding to LMH cells as compared to *capA* expressing control strains. Two other proteins, KpsE and KpsM, which are involved in capsule production have also been implicated as playing a role in invasion. *In vivo* experiments using *kpsE* and *kpsM* mutants in the ferret model have indicated the role played by the capsule in colonization (Bacon et al., [@B7]; Bachtiar et al., [@B4]). Another proposed adhesin is Cj0977 (Goon et al., [@B29]), but later studies have shown that reduced binding maybe due to a deficiency in motility in liquid broth (Novik et al., [@B74]), although the mutants were motile on soft agar plates (Goon et al., [@B29]). Furthermore, another study has revealed the role played by lipooligosaccharide (LOS) sialylation as mutants in the *cstII* gene showed reduced ability to enter epithelial cells (Louwen et al., [@B63]). Other proteins recently identified as affecting adherence and invasion levels also include the chaperone and serine protease HtrA (Baek et al., [@B8]) and VirK (Novik et al., [@B73]). Baek et al. showed that the chaperone activity of HtrA in the periplasm may affect proper folding of adhesins involved in host cell binding, whereas Novik et al. pointed out that the reduction of intracellular bacteria observed in the gentamycin protection assay (GPA) with a *virK* mutant may be primarily due to a ∼100-fold increase in susceptibility to certain antimicrobial peptides. Finally, although some genes have been identified on the pVIR plasmid in strain 81-176 to play a role in invasion, these genes seem to be strain-specific as they are only present in a very small subset (∼10%) of *C. jejuni* isolates (Bacon et al., [@B5], [@B6]).

The Cellular Invasion Process
=============================

Early reports which investigated intestinal biopsies from human patients indicated that *C*. *jejuni* is able to enter gut tissue cells *in vivo* (van Spreeuwel et al., [@B93]). Numerous studies have then shown that *C. jejuni* can invade and survive within a number of cultured cell lines *in vitro* (Table [2](#T2){ref-type="table"}). Various *C. jejuni* factors permitting motility, glycosylation, capsular synthesis, and adherence have been implicated in the invasion process (Grant et al., [@B30]; Yao et al., [@B97]; Pei et al., [@B76]; Bacon et al., [@B7]; Konkel et al., [@B56]; Szymanski et al., [@B88]). Very commonly, *C. jejuni* with introduced mutations in these genes exhibited various degrees of deficiency in binding to and entering human target cells, or in colonizing certain animal models including chicken and mice (Hendrixson and DiRita, [@B33]; Kakuda and DiRita, [@B43]; Watson and Galán, [@B94]; Novik et al., [@B74]). A common laboratory method to monitor adherence and invasion is GPA, but also immunofluorescence and electron microscopy (EM) approaches have been utilized in some but not all studies (Table [2](#T2){ref-type="table"}). However, it is not yet clear which mechanism of invasion, "zipper" or "trigger," is used by *C. jejuni*. High resolution EM investigation of infected non-polarized INT-407 and other cell lines indicated that *C. jejuni* induces membrane ruffling in a contact-dependent manner followed by host cell entry, first with its flagellar tip followed by the opposite flagellar end (Krause-Gruszczynska et al., [@B59], [@B57]; Boehm et al., [@B12]), surprisingly sharing some features of both "zipper"- and "trigger"-mechanisms (Figure [1](#F1){ref-type="fig"}C).

###### 

**Host factors and proposed roles in *C. jejuni* infections**.

  Host factor             Proposed function                       Applied experimental methods                                                                        Strains used                              Cell system used                                      Reference
  ----------------------- --------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------------- ----------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------
  Actin filaments         Invasion                                Infection *in vitro*, cytochalasin D and mycalolide B inhibitors, GPA, IFM                          81116, HP5100, CCUG7800, F38011, 81-176   INT-407                                               Biswas et al. ([@B11]), Monteville et al. ([@B68])
  Calcium                 Invasion                                Infection *in vitro*, BAPTA inhibitors, GPA                                                         81-176                                    INT-407                                               Hu et al. ([@B39])
  Cdc42                   Invasion                                Infection *in vitro*, CA and DN constructs, GMT, CRIB-PD, GPA, IF, FESEM                            81-176, 84-25, F38011                     INT-407; ^−/−^ cell lines                             Krause-Gruszczynska et al. ([@B59], [@B57])
  Caveolae                Invasion                                Infection *in vitro*, filipin-III and MβCD inhibitors, DN constructs, GPA, IFM                      N82, 81-176                               Caco-2, INT-407, Cos-1                                Wooldridge et al. ([@B96]), Hu et al. ([@B38]), Watson and Galán ([@B94])
  DOCK180                 Rac-1 activation, invasion              Infection *in vitro*, siRNA, GPA                                                                    F38011, 81-176, 84-25                     HeLa, INT-407                                         Eucker and Konkel ([@B24]), Boehm et al. ([@B12])
  Dynein                  Invasion, intracellular trafficking     Infection *in vitro*, nocodazole and o-Van inhibitor, GPA, IFM                                      81-176                                    INT-407                                               Hu and Kopecko ([@B36])
  EGF receptor            Invasion                                Infection *in vitro*, ABB, PD168393 and erlotinib inhibitors, DN constructs, GPA                    F38011, 81-176, 84-25                     INT-407                                               Eucker and Konkel ([@B24]), Krause-Gruszczynska et al. ([@B57])
  FAK                     Invasion signaling                      Infection *in vitro*, TAE226 and PF573228 inhibitors, DN and other constructs, GPA, FESEM           F38011, 81-176, 84-25                     INT-407, FAK^−/−^cells                                Krause-Gruszczynska et al. ([@B57]), Eucker and Konkel ([@B24]), Boehm et al. ([@B12])
  Fibronectin             Adhesion, invasion                      Binding and infection *in vitro*, CBA, TWA, ABB, use of *cadF* mutant, GPA, FESEM                   F38011, 81-176, 84-25                     INT-407, T84, Fn^−/−^cells                            Monteville and Konkel ([@B67]); Monteville et al. ([@B68]), Krause-Gruszczynska et al. ([@B57]), Boehm et al. ([@B12])
  G proteins              Invasion                                Infection *in vitro*, pertussis and cholera toxin treatments, GPA                                   N82, 81-176                               Caco-2, INT-407                                       Wooldridge et al. ([@B96]), Hu et al. ([@B38])
  Integrin β1             Adhesion, invasion signaling            Infection *in vitro*, CRIB-PD, G-lisa, GPA, FESEM                                                   81-176, 84-25, F38011                     Integrin β1^−/−^ cells                                Boehm et al. ([@B12])
  Lysosomes               Intracellular trafficking               Infection *in vitro*, IFM with EEA-1, Lamp-1, Rab4, and Rab5                                        81-176                                    Cos-1                                                 Watson and Galán ([@B94])
  MAPK                    Inflammatory signaling, invasion        Infection *in vitro*, binding of GST-JlpA *in vitro*; AABs for Erk, JNK, and p38; MAPK inhibitors   THG9011, 81-176, 11168                    HEp-2, T84, Caco-2, human colonic explants, INT-407   Jin et al. ([@B42]), MacCallum et al. ([@B64]), Chen et al. ([@B16]), Hu et al. ([@B38])
  Microtubule filaments   Invasion                                Infection *in vitro*; nocodazole inhibitor                                                          81-176, VC84                              INT-407                                               Oelschlaeger et al. ([@B75])
  Mucin (chicken)         Inhibition of bacterial virulence       Binding studies, GPA                                                                                81-176                                    HCT-8                                                 Alemka et al. ([@B1])
  Myd88                   Colonization controlled by TLRs         Colonization of Myd88^−/−^ but not wt control mice                                                  81-176                                    Myd88^−/−^mice                                        Watson et al. ([@B95])
  NF-κB                   Inflammatory signaling                  Binding of GST-JlpA *in vitro*, AABs, cytokine release                                              THG9011                                   HEp-2                                                 Jin et al. ([@B42])
  Nramp1                  Colonization of mice                    Colonization enhanced in Nramp1^−/−^ mice                                                           81-176                                    Nramp1^−/−^mice                                       Watson et al. ([@B95])
  Occludin                Impaired epithelial barrier functions   Infection *in vitro*, TER, hyperphosphorylation of occludin, NF-κB activation, AABs, GPA            81-176, 11168                             T84                                                   Chen et al. ([@B16])
  Paxillin                Invasion                                Phosphorylation of paxillin, infection *in vitro*, IP, AAB, GPA                                     F38011                                    INT-407                                               Monteville et al. ([@B68])
  PDGF receptor           Invasion                                Infection *in vitro*, AG370 inhibitor, DN constructs, GPA                                           F38011, 81-176, 84-25                     INT-407                                               Krause-Gruszczynska et al. ([@B57])
  PI3-kinase              Invasion                                Infection *in vitro*, LY294002 and wortmannin inhibitors, GPA, Vav2 constructs                      N82, 81-176, 27 clinical strains          INT-407                                               Wooldridge et al. ([@B96]), Hu et al. ([@B38]), Biswas et al. ([@B10]), Krause-Gruszczynska et al. ([@B57])
  PKC                     Invasion                                Infection *in vitro*, calphostin C inhibitor, GPA                                                   81-176, 27 clinical strains               INT-407                                               Hu et al. ([@B39]), Biswas et al. ([@B10])
  Rac-1                   Invasion                                Infection *in vitro*, CA and DN constructs, GMT, CRIB-PD, G-lisa, GPA, IFM, FESEM                   81-176, F38011, 84-25                     INT-407, ^−/−^ cell lines                             Krause-Gruszczynska et al. ([@B59]), Eucker and Konkel ([@B24]), Boehm et al. ([@B12])
  Src kinases             Invasion                                Infection *in vitro*, PP2 inhibitor, GPA                                                            F38011                                    INT-407, SYF cells                                    Eucker and Konkel ([@B24]), Krause-Gruszczynska et al. ([@B57])
  Tiam-1                  Rac-1 activation, invasion              Infection *in vitro*, DN and other constructs, siRNA, GPA                                           81-176, F38011, 84-25                     INT-407, ^−/−^ cells                                  Boehm et al. ([@B12])
  Vav2                    Cdc42 activation, invasion              Infection *in vitro*, DN and other constructs, siRNA, GPA                                           81-176, F38011, 84-25                     INT-407, Vav^−/−^ cells                               Krause-Gruszczynska et al. ([@B57])

*AB, antibody; AAB, activation-specific antibody; ABB, antibody blocking; CBA, competitive binding assay; MβCD, methyl-beta cyclodextrin; CA constructs, constitutive-active constructs; DN constructs, dominant-negative constructs; IP, immunoprecipitation; CRIB-PD, pull-down experiments to quantify GTPase-GTP levels; EEA-1, early endosomal marker 1; FAK, focal adhesion kinase; FESEM, field emission scanning electron microscopy; Fn, Fibronectin, G-lisa, ELISA-based GTPase-GTP quantification system; GPA, gentamicin protection assay, GST-JlpA, glutathione-*S*- transferase-tagged JlpA; GMT, GTPase-modifying toxins such as toxin B or CNF, which either inhibit or activate GTPases; IFM, immunofluorescence microscopy; IP, immunoprecipitation; MAPK, mitogen-activated protein kinases; MyD88, myeloid differentiation factor 88; *o*-Van, ortho-vanadate inhibitor; PKC, protein kinase C; SYF, Src^−/−^, Yes^−/−^, Fyn^−/−^ triple knockout cells; TER, transepithelial resistance; TWA, transwell assays with polarized cells; Vav2, guanine exchange factor of the Vav family; wt, wild-type; ^−/−^, knockout cells*.

Putative Host Cell Receptors and Kinases Involved in the Invasion Process
=========================================================================

Lipid rafts are specific microdomains of plasma membrane of eukaryotic host cells which are enriched in cholesterol and sphingolipids, and favor the interactions of receptor molecules and the regulation of downstream signaling pathways. Pharmacological inhibitor studies using the lipid raft-disrupting compounds filipin-III or MβCD as well as certain toxins have indicated that host heterotrimeric G proteins and caveolae may be involved in epithelial cell entry of *C. jejuni* (Wooldridge et al., [@B96]; Hu et al., [@B38]; Watson and Galán, [@B94]). Expression of dominant-negative mutants of caveolin-1 but not dynamin-II significantly decreased *C. jejuni* internalization (Watson and Galán, [@B94]), suggesting that caveolin-1 in caveolae structures may play a role in the uptake process (Figure [2](#F2){ref-type="fig"}). Interestingly, *C. jejuni* is severely hampered in its ability to invade cell lines derived from fibronectin^−/−^, integrin-β1^−/−^, focal adhesion kinase (FAK)^−/−^, and Src^−/−^/Yes^−/−^/Fyn^−/−^ (SYF) triple knockout mice using EM and/or GPA, but can efficiently enter wild-type control cells (Krause-Gruszczynska et al., [@B57]; Boehm et al., [@B12]). Infection of integrin-β1^−/−^ knockout cells stably expressing integrin-β1 point mutants with well-known defects in extracellular fibronectin fibril formation or intracellular FAK signaling also exhibited severe deficiencies in *C. jejuni* invasion (Krause-Gruszczynska et al., [@B57]). Novel data also showed that FAK and certain receptor protein tyrosine kinases such as EGF receptor (EGFR) and platelet derived growth factor receptor (PDGFR) are activated by *C. jejuni* and involved in the uptake process (Krause-Gruszczynska et al., [@B57]; Boehm et al., [@B12]; Eucker and Konkel, [@B24]). Another focal adhesion signaling molecule, paxillin, also exhibited increased levels of tyrosine phosphorylation upon *C. jejuni* infection, which was not seen during infection with mutants of the fibronectin binding protein CadF (Monteville et al., [@B68]). These data collectively suggest that the CadF → fibronectin → integrin-β1 → FAK → paxillin pathway is another major signaling cascade involved in *C. jejuni*-mediated host cell entry (Figure [2](#F2){ref-type="fig"}). In addition, inhibitor studies combined with GPA have suggested that phosphatidylinositol 3-kinase (PI3-kinase), protein kinase C (PKC), and mitogen-activated protein kinases (MAPKs) are involved in events controlling *C. jejuni* internalization (Wooldridge et al., [@B96]; Biswas et al., [@B10]; Hu et al., [@B38]). Other inhibitor-based work has also shown that Ca^2+^ release from host intracellular stores is essential for efficient *C. jejuni* recovery by GPA (Hu et al., [@B39]). However, whether most of the latter factors are directly involved in the bacterial entry step or trafficking linked to intracellular bacterial survival is not yet clear.

![**Hypothetical model for *C. jejuni*-induced signaling events leading to bacterial invasion and establishing infections**. *C. jejuni* adheres to host cells via numerous reported and unknown factors. Several indicated host cell receptors have been proposed to play a role in the uptake of the bacteria. This potentially causes localized F-actin and/or microtubule rearrangements at the site of *C. jejuni* entry, resulting in engulfment and bacterial uptake. Several indicated host cell signaling molecules and pathways including the intracellular survival in *Campylobacter-*containing vacuoles (CCVs) have been reported in *in vitro* infection models and may play a role during pathogenesis *in vivo*. For more details, see tables and text.](fcimb-02-00025-g002){#F2}

Function of GEFs and Small Rho GTPases in *C. jejuni* Invasion
==============================================================

The Rho family of small GTPases, including Rac-1, Cdc42, and RhoA, are small GTP-binding proteins that serve as guanine nucleotide-regulated switches which transmit external stimuli to modulate different normal cellular functions as well as invasion of multiple bacterial pathogens (Cossart and Sansonetti, [@B18]). The internalization of *C. jejuni* into INT-407 cells is accompanied by a time-dependent activation of both Rac-1 and Cdc42 (Krause-Gruszczynska et al., [@B59], [@B57]; Boehm et al., [@B12]; Eucker and Konkel, [@B24]). Using specific GTPase-modifying toxins, inhibitors, and GTPase expression constructs it was shown by immunofluorescence, GPA, and other studies that Rac-1 and Cdc42, but not RhoA, are involved in *C. jejuni* invasion (Krause-Gruszczynska et al., [@B59]). Interestingly, the activation of these GTPases and induction of membrane ruffling by *C. jejuni* was severely inhibited in infected fibronectin^−/−^, integrin-β1^−/−^, FAK^−/−^, and SYF^−/−^ knockout cell lines, although the bacteria had intact flagella and bound to their cell surface (Krause-Gruszczynska et al., [@B57]; Boehm et al., [@B12]). Maximal GTPase--GTP levels induced by *C. jejuni* also involve EGFR, PDGFR, FAK, Src, and PI3-kinase activities as supported by inhibitor studies, and the bacterial fibronectin binding protein CadF as well as the flagellum and one secreted *Campylobacter* invasion antigen, CiaC (Krause-Gruszczynska et al., [@B59], [@B57]; Eucker and Konkel, [@B24]). Immunofluorescence data also indicated that CiaC is essential for recruitment of Rac-1 to the site of *C. jejuni* adherence (Eucker and Konkel, [@B24]). The exact role of CiaC, however, is not yet clear, but it would appear that it does not encode a guanine exchange factor (GEF) for activating Rac-1. CiaC shares no sequence homology with the well-known GEFs from *Shigella* *flexneri* or *Salmonella* *enterica*, which are directly injected into the host cell by a T3SS and known to induce extensive membrane ruffling by the "trigger" mechanism (Cossart and Sansonetti, [@B18]). In agreement with these observations, two host cell GEFs (DOCK180 and Tiam-1) were identified to trigger Rac-1 activity downstream of FAK based on small inhibitory RNA (siRNA) knockdown, inhibitors, and the use of FAK^−/−^ knockout cell experiments (Boehm et al., [@B12]; Eucker and Konkel, [@B24]), while another GEF (Vav2) is downstream of FAK, EGFR, PDGFR, and PI3-kinase to trigger Cdc42 GTPase activity (Krause-Gruszczynska et al., [@B57]). Collectively, these results suggest that *C. jejuni* actively triggers signaling to stimulate their own uptake by host target cells using a unique mechanism and the activation of the Rho GTPase members Rac-1 and Cdc42 plays a crucial role in this entry process (Figures [1](#F1){ref-type="fig"}C and [2](#F2){ref-type="fig"}).

Role of Microfilaments Versus Microtubules during Invasion
==========================================================

Microfilaments (MFs) and microtubules (MTs), which are composed of actin or tubulin subunits, respectively, play an important role in cell architecture and other basic cellular processes. Using inhibitor and GPA studies, *C. jejuni* internalization has been variously reported to require MTs (Oelschlaeger et al., [@B75]; Hu and Kopecko, [@B37]), MFs (De Melo et al., [@B20]; Konkel and Joens, [@B52]), both MTs and MFs (Oelschlaeger et al., [@B75]; Biswas et al., [@B11]; Monteville et al., [@B68]), or neither MTs or MFs (Russell and Blake, [@B83]). Other studies investigated the co-localization of infecting *C. jejuni* with MTs and the molecular motor protein dynein (Hu and Kopecko, [@B36]), but also with MFs (Konkel et al., [@B50]; Rivera-Amill et al., [@B81]; Krause-Gruszczynska et al., [@B59]). This available data, although not sufficient to allow definitive conclusions, suggest that different *C. jejuni* strains may prefer MT-dependent or MF-dependent pathways for host invasion, while others may depend on both MTs and MFs during invasion. Remarkably, after about 20 years of research, the *C. jejuni*-mediated triggers which result in MT and/or MF rearrangements to facilitate bacterial uptake are still not clear. It will therefore be important to investigate how activated caveolae, FAK, EGFR, PDGFR, PI3-kinase, Rac-1, Cdc42, or other host factors could potentially stimulate MFs and/or MTs dynamics to mediate the *C. jejuni* entry process.

Intracellular Trafficking and Survival of *C. jejuni*
=====================================================

Various intracellular pathogens utilize a variety of strategies to live and replicate within host cells. GPA and EM studies have shown that *C. jejuni* can survive for extended periods of time in several cell lines and tissues (Table [2](#T2){ref-type="table"}). Following entry into intestinal epithelial cells, *C. jejuni* appears to localize in a specific compartment in the cytoplasm, which seems to be distinct from the lysosomes (Watson and Galán, [@B94]). It was found that the *C. jejuni*-containing vacuole (CCV) deviates from the canonical endocytic pathway immediately after host cell entry, thus avoiding delivery into lysosomes (Figure [1](#F1){ref-type="fig"}D). The CCV appears to interact with early endosomal compartments because it associates with early endosomal marker protein EEA-1 and two trafficking GTPases, Rab4, and Rab5 (Figure [2](#F2){ref-type="fig"}, right). However, this interaction seems only transient and does not progress inside the canonical endocytic pathway (Watson and Galán, [@B94]). The CCV can be also stained with Lamp-1, a late endosomal marker, although this compartment appears to be unique and clearly distinct from lysosomes (Figure [2](#F2){ref-type="fig"}). CCVs were not stainable with the lysosomal marker protein cathepsin B and it is also not accessible to certain endocytic tracers (Watson and Galán, [@B94]). Taken together, the acquisition of Lamp-1 occurring very early during maturation of CCVs, appears to proceed by an unusual pathway not requiring the GTPases Rab5 or Rab7, although recruited to the CCV. More studies are required to elucidate in more detail the mechanism by which *C. jejuni* modulates intracellular trafficking and survival.

The subset of *C. jejuni* genes which are important for intracellular trafficking and survival are widely unknown, but a couple of potential factors are emerging. One of these factors is CiaI, a reported secreted protein (Buelow et al., [@B14]). A *ciaI* mutant was impaired in intracellular survival by GPA. Immunofluorescence examination indicated that the *ciaI* mutant more frequently co-localized with Cathepsin D in the CCVs as compared to wild-type bacteria, and is probably killed in these compartments. In another recent study, insertional mutation of three novel genes named *aspA*, *aspB*, and *sodB* also exhibited clear defects in intracellular recovery by GPA (Novik et al., [@B74]). Further characterization of these mutants revealed that the reduction in recovered bacteria was due to a combined defect in adhesion and impaired intracellular viability (SodB) or undetermined effects on bacterial physiology (AspA and AspB). These studies highlight the importance of the use of multiple assays to identify and characterize genes which play potential roles in *C. jejuni* adherence and invasion.

Urgent Problems to be Solved
============================

*Campylobacter jejuni* is a remarkable foodborne microbe, but by comparison to other well-known enteric pathogens, we know very little about the bacterial and host factors involved in establishing infection and triggering disease. This dilemma is in part due to the clear absence of classical bacterial adhesins, toxins, or typical T3SSs or T4SSs in the sequenced *C. jejuni* genomes. The other enormous handicap is the large amount of highly conflicting data in the literature. For almost every reported factor proposed to be involved in a given host response, there is at least one other study showing the opposite. It is possible that the reported results depend on the specific strains used, how the bacteria were grown, but also on differences in the experimental conditions and applied methodology (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). In addition, many studies using single mutants lack genetic complementation of the corresponding wild-type gene, which although technically very difficult in *C. jejuni*, would be very useful to restore the phenotypes reported for many of the aforementioned pathogenicity factors. Furthermore, one must be very careful when using methods such as GPA as an accurate measurement of bacterial invasion. GPA determines the number of viable CFU protected from gentamicin, and thus represents a direct measurement of intracellular surviving bacteria, rather than a direct measure of the invasion process itself? Some studies have identified factors which appear to play a direct role in invasion when studied using GPA, but when studied using other methods are actually revealed to have an indirect role. These include AspA and AspB whose primary role was shown to be in the production of fumarate but when mutated displayed a reduction in invasion by the GPA assay (Novik et al., [@B74]). However, this effect could be reversed by the addition of fumarate showing that this reduction was due to physiological effects rather than these proteins functioning as adhesins or invasins directly (Novik et al., [@B74]). Studies such as these highlight how important it is to use a variety of experimental approaches to identify and study any factors found to play a role in host cell interactions. The same arguments apply for certain studies using pharmacological inhibitors. Besides such problems as the lack of controls, it should be asked if these inhibitors or their solvents alone have specific activities on the host or bacteria over time and, if properly performed, does a given compound really inhibit the entry process itself or does it interfere with bacterial survival in the CCVs? GPA certainly does not discriminate between these different possibilities either. Thus, in future, more direct methods such as novel microscopic technologies are necessary to investigate in detail the involvement of certain host factors in bacterial engulfment and uptake, but also in intracellular survival processes.

Although several of the discussed GPA studies have identified certain *C. jejuni* gene mutants exhibiting severe defects in entering or surviving in cells, there is no direct evidence yet that any of the identified gene products can directly trigger invasion (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). For example, it is still controversial if the role of the flagellum during invasion is restricted to bacterial motility or secretion of bacterial Cia proteins into the medium or even injection into the host cell. This model of Cia protein secretion through the flagellum is very tempting and would support the idea that *Campylobacter* uses a "trigger mechanism" of invasion involving the secretion of effector proteins directly into the cell to induce their uptake, similar to *Salmonella* and *Shigella*. Some electron microscopic evidence exists that would support this model (Figure [1](#F1){ref-type="fig"}C), but it should be noted that a recent study has suggested that CiaB plays a minimal or no role in invasion (Novik et al., [@B74]). Thus, much more work is required to confirm the role of the flagellum as a secretion system for effector proteins involved in invasion.

Confusion also exists as to the exact role played by some of the previously proposed adhesins. Proteins such as JlpA have been described by some authors as being an important adhesin (Jin et al., [@B41]), whereas other groups have been unable to show any significant decrease in invasion in a *jlpA* mutant (Novik et al., [@B74]). Furthermore, factors such as the PEB proteins which were originally described as adhesins (Pei et al., [@B78]) now appear to primarily have roles as transporters (Leon-Kempis Mdel et al., [@B61]) or as chaperones (Kale et al., [@B44]), suggesting that they may not directly interact with the host cell but play a more indirect role. One protein that is very well characterized and appears to clearly play a role in adherence to host epithelial cells is CadF (Monteville et al., [@B68]). This protein along with the recently described FlpA protein (Flanagan et al., [@B26]) appears to bind to fibronectin and specific fibronectin binding sites have been identified in CadF (Konkel et al., [@B47]). The importance of CadF has been observed in a large number of strains and using a variety of different experimental approaches (Table [1](#T1){ref-type="table"}). Thus, targeting the fibronectin/integrin receptor could explain why *C. jejuni* may try to reach basolateral surfaces during infection (van Alphen et al., [@B92]). How the bacteria breach this epithelial barrier, by a transcellular route (Figure [1](#F1){ref-type="fig"}D) or a paracellular route (Figure [1](#F1){ref-type="fig"}E), is also under much debate and not yet clear (Konkel et al., [@B51]; Grant et al., [@B30]; Brás and Ketley, [@B13]; Monteville and Konkel, [@B67]; Hu et al., [@B40]; Kalischuk et al., [@B45]). However, the underlined importance of CadF and the fibronectin/integrin might give support to a "zipper"-like mechanism of invasion as used by *Listeria* or *Yersinia* species.

Concluding Remarks
==================

In conclusion it is very difficult at present to conclusively state how *C. jejuni* facilitates its uptake into host epithelial cells. There is evidence in the literature and specifically EM images which give some support for both the "zipper" and "trigger" mechanisms of invasion, underlining the concept that *C. jejuni* enters epithelial cells by a unique novel mechanism. It may be that *C. jejuni* has developed during evolution a strategy which shares features of both of these mechanisms, but more work is clearly required to pinpoint the exact pathways used by this important pathogen to enter and survive in intestinal epithelial cells. At the moment, we favor a model where at least two major receptor-involved pathways give rise to *C. jejuni* invasion, the fibronectin/integrin, and caveolae structures (Figure [2](#F2){ref-type="fig"}). We also consider that caveolae and integrin may act cooperatively in GTPase signaling as shown for other cell systems (del Pozo et al., [@B21]; del Pozo and Schwartz, [@B22]). Future studies should investigate how this occurs and what are the forces triggered by the host cell that mediate engulfment, uptake, and also membrane closure behind the entering bacteria. It will be also important to investigate, in more detail, the mechanisms by which *C. jejuni* survives and spreads intracellularly as well as how it causes extra-intestinal infection in organs such as the liver in various animals (Hofreuter et al., [@B34]; Cox et al., [@B19]). It therefore appears that *C. jejuni* will continue to be a fascinating and rewarding research subject in the future.
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